Options: Hide MedDRA Preferred Terms
MedDRA Preferred Term | Side effect | Data for drug | Placebo | Labels | |
---|---|---|---|---|---|
1 | 2 | ||||
Eyelid oedema | Eyelid oedema | 2.8% | x | x | |
Punctate keratitis | Punctate keratitis | 2% | x | ||
Superficial punctate keratopathy | x | ||||
Hyperaemia | Hyperaemia | x | |||
Hypersensitivity | Hypersensitivity | x | |||
Nausea | Nausea | x | |||
Intraocular pressure increased | Intraocular pressure increased | x | x | ||
Keratopathy | Keratopathy | x | |||
Vision blurred | Vision blurred | x | |||
Corneal oedema | Corneal stromal edema | x | x | ||
Pain | Stinging | x | |||
Dry eye | Keratitis sicca | x | x |
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |